Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

China flag China · Delayed Price · Currency is CNY
6.56
-0.35 (-5.07%)
Jul 30, 2026, 3:04 PM CST
Market Cap3.48B +2.2%
Revenue (ttm)1.03B +1.3%
Net Income225.27M +30.0%
EPS0.45 +29.9%
Shares Out 503.20M
PE Ratio15.44
Forward PEn/a
Dividend0.30 (4.29%)
Ex-Dividend DateJun 16, 2026
Volume46,685,600
Open7.08
Previous Close6.91
Day's Range6.53 - 7.08
52-Week Range5.32 - 8.60
Beta0.35
Analystsn/a
Price Targetn/a
Earnings DateAug 25, 2026

About SHE:002412

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers medications for digestive, cardiovascular, cerebrovascular, and urological diseases, as well as for traumatology and diagnostic applications. It provides its products in various forms, including injections, mixtures, tablets, capsules, granules, syrups, decoctions, tinctures, and pills. Hunan Hansen Pharmaceutical Co., Ltd. was founded in 1998 and is based in Yiyang, China. [Read more]

Sector Healthcare
Founded 1998
Employees 2,108
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002412
Full Company Profile

Financial Performance

In 2025, SHE:002412's revenue was 1.04 billion, an increase of 3.41% compared to the previous year's 1.00 billion. Earnings were 198.12 million, a decrease of -10.05%.

Financial Statements